Company: HMDCF
Filing Date: 2025-03-19
Form Type: 20-F
Source: 0001410578-25-000377
Chunk: 298

Company: HUTCHMED (China) Ltd
Filing Date: 2025-03-19
Form: 20-F
Item: Item 1
Chunk 298
---
 expenses increased by 0.9% to $152.0 million for the year ended December 31, 2024 from $150.7 million for the year ended December 31, 2023, as a result of increased spending on marketing activities to support the increase in sales.

Administrative expenses increased by 0.6% to $16.9 million for the year ended December 31, 2024 from $16.8 million for the year ended December 31, 2023, as a result of increase in staff costs to support commercial activities.

Research and development expenses increased by 48.4% to $13.8 million for the year ended December 31, 2024 from $9.3 million for the year ended December 31, 2023, primarily due to increase in costs for product development.

Other net operating income increased by 2.5% to $5.2 million for the year ended December 31, 2024 from $5.0 million for the year ended December 31, 2023, primarily due to an increase in government grants.

Taxation charge decreased by 6% to $16.0 million for the year ended December 31, 2024 from $17.0 million for the year ended December 31, 2023, primarily due to a decrease in taxable profit.

As a result of the foregoing, profit decreased by 2.7% to $92.9 million for the year ended December 31, 2024 from $95.5 million for the year ended December 31, 2023. Our equity in earnings of equity investees contributed by this joint venture was $46.5 million and $47.3 million for the years ended December 31, 2024 and 2023, respectively.

Table of Contents

For more information on the financial results of our non-consolidated joint ventures, see“ - Key Components of Results of Operations - Equity in Earnings of Equity Investees. ”

Net Income

As a result of the foregoing, our net income decreased from $101.1 million for the year ended December 31, 2023 to $38.2 million for the year ended December 31, 2024. Net income attributable to our company decreased from $100.8 million for the year ended December 31, 2023 to $37.7 million for the year ended December 31, 2024.

Year Ended December 31, 202